Skip to content

ITRAQ and Label Free technology based on proteomics for aortic dissection Molecular markers

ITRAQ and Label Free technology based on proteomics for aortic dissection Molecular markers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015743
Enrollment
Unknown
Registered
2018-04-18
Start date
2017-05-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic dissection

Interventions

Sponsors

Southern Medical University Zhujiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Test group: (1) above 18 years old male and female; (2) Patients with chest pain and onset in 72 hours; (3) Acute aortic dissection patients undergoing aortic CT or angiography Confirmed. Control group: (1) above 18 years old male and female; (2) Patients with non-aortic dissection chest pain.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) History of cardiopulmonary resuscitation (CPR) and cardiac intervention or surgery for 1 week; (3) Severe liver and kidney insufficiency; (4) Patients in shock state at admission Vasoactive drugs are needed.

Design outcomes

Primary

MeasureTime frame
lumican;

Countries

China

Contacts

Public ContactQiang Fu

Southern Medical University Zhujiang Hospital

fuqiang020@126.com+86 13189097970

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026